The study findings have been published ahead of their official publication in the online version of Exp. Mol. Med. on August 1, 2023.
Abstract Autophagy functions in cellular quality control and metabolic regulation. Dysregulation of autophagy is one of the major pathogenic factors contributing to the progression of nonalcoholic fatty liver disease (NAFLD). Autophagy is i... Read More
The study findings have been published ahead of their official publication in the online version of Nucleic Acids Research on June 28, 2023.
Abstract Replication protein A (RPA), a eukaryotic single-stranded DNA (ssDNA) binding protein, dynamically interacts with ssDNA in different binding modes and plays essential roles in DNA metabolism such as replication, repair, and recombi... Read More
UNIST New Center has selected the top 10 news stories of 2018 based on the number of page views.
As always, UNIST continued to move towards its dream of becoming “World-leading university to advance science and technology for the prosperity of humankind”. The year 2018 has been especially successful and full of inspiring ne... Read More
The title 'Rising-star Distinguished Professor' is awarded to eminent professors who are under the age of 45.
UNIST is pleased to announce the selection of 6 extraordinary scholars to be induced as ‘Rising-star Distinguished Professor’, the highest honor the university can bestow upon faculty members who are under the age of 45. Honored... Read More
Research, led by Prof. Jang Hyun Choi appeared in the world-leading scientific journal, Diabetes.
Leukemia drug holds promise for patients with type 2 diabetes.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 d... Read More